You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 7, August 18, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Myocardial Infarction Associated With Ovarian Hyperstimulation Syndrome

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Ovarian hyperstimulation syndrome is one of the most severe complications following controlled ovarian stimulation. Fluid redistributes from intravascular to extravascular spaces (ie, the abdominal or pleural cavity) leading to ascites and pleural effusions. Most patients can be treated successfully with intravascular fluids and thrombosis prophylaxis. However, complications such as thrombosis and even death have been reported.1 We report the first case, to our knowledge, of a patient with myocardial infarction after ovarian hyperstimulation syndrome.

Report of a Case.

A 35-year-old patient (77 kg, 170 cm) presented to our department with secondary male subfertility. She smoked 30 cigarettes per day. An in vitro fertilization intracytoplasmic sperm injection cycle was planned. A decapeptyl depot (3.75 mg) preparation was administered and recombinant follicle-stimulating hormone (150 IU) was started 2 weeks later. The dosage of recombinant follicle-stimulating hormone was increased to 225 IU on the fifth day, and human chorionic gonadotropin (10,000 IU) was given . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Radiographic Vertebral Fracture a Risk Factor for Mortality?
Trone et al.
Am J Epidemiol 2007;166:1191-1197.
ABSTRACT | FULL TEXT  

Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals
Ludwig et al.
Hum Reprod 2006;21:3235-3240.
ABSTRACT | FULL TEXT  

Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report
Rao et al.
Hum Reprod 2005;20:3307-3312.
ABSTRACT | FULL TEXT  

Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report
Ou et al.
Hum Reprod 2003;18:2375-2381.
ABSTRACT | FULL TEXT  

Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome: An aggressive, but perhaps life-saving procedure
Amarin
Hum Reprod 2003;18:659-664.
ABSTRACT | FULL TEXT  

Perforated duodenal ulcer associated with ovarian hyperstimulation syndrome: Case Report
Uhler et al.
Hum Reprod 2001;16:174-176.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.